Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the study details are currently unavailable due to permission or server issues.SummaryDifference19%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA 2015 U.S. NIH Grant/Contract note and the rheumatoid arthritis topic were added, along with a related topics link to MedlinePlus Genetics. The revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page no longer lists the disease tag 'Rheumatoid arthritis' and the related topics section (MedlinePlus Genetics), removing key disease-specific context and external references.SummaryDifference0.1%

- Check54 days agoChange DetectedThe footer revision label changed from v3.6.4 to v3.6.5, representing a small update to the page's versioning descriptor without altering the displayed study details.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page adds 'Rheumatoid arthritis' as a related topic and links to MedlinePlus Genetics under related topics, and the page revision advances from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s related topics section loses the entries for Rheumatoid arthritis and MedlinePlus Genetics, decreasing the topic metadata associated with the study.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.